Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Scott B. Willoughby currently holds 651,406 shares of SANGAMO THERAPEUTICS, INC (SGMO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott B. Willoughby has been a net neutral trader of SGMO stock. They have purchased $0 and sold $0 worth of shares.
Scott B. Willoughby's most recent insider trade was on Feb 25, 2026, when they sold 12,354 shares at $0.47 per share.
Scott B. Willoughby serves as Executive at SANGAMO THERAPEUTICS, INC (SGMO). They have executed 29 insider transactions totaling $0 over their tenure at the company.
Scott B. Willoughby holds the position of Executive at SANGAMO THERAPEUTICS, INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Scott B. Willoughby has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Scott B. Willoughby was on Oct 22, 2025, when they sold $29.1K worth of SGMO shares. This transaction involved 44,122 shares at $0.66 per share.
Scott B. Willoughby currently owns 651,406 shares of SANGAMO THERAPEUTICS, INC (SGMO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Scott B. Willoughby's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Scott B. Willoughby has 29 Form 4 filings on record as an insider at SANGAMO THERAPEUTICS, INC.
Set alerts for Scott B. Willoughby and 40,000+ other insiders.